113 related articles for article (PubMed ID: 11341777)
1. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP.
Yoon CS; Kim KD; Park SN; Cheong SW
Biochem Biophys Res Commun; 2001 May; 283(3):668-73. PubMed ID: 11341777
[TBL] [Abstract][Full Text] [Related]
2. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses.
Evander M; Frazer IH; Payne E; Qi YM; Hengst K; McMillan NA
J Virol; 1997 Mar; 71(3):2449-56. PubMed ID: 9032382
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
4. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
[TBL] [Abstract][Full Text] [Related]
5. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
Luxton JC; Rose RC; Coletart T; Wilson P; Shepherd PS
J Gen Virol; 1997 Apr; 78 ( Pt 4)():917-23. PubMed ID: 9129666
[TBL] [Abstract][Full Text] [Related]
6. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
7. Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells.
McMillan NA; Payne E; Frazer IH; Evander M
Virology; 1999 Sep; 261(2):271-9. PubMed ID: 10497112
[TBL] [Abstract][Full Text] [Related]
8. alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4.
Sibbet G; Romero-Graillet C; Meneguzzi G; Campo MS
J Gen Virol; 2000 Feb; 81(Pt 2):327-34. PubMed ID: 10644830
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein.
Qi YM; Peng SW; Hengst K; Evander M; Park DS; Zhou J; Frazer IH
Virology; 1996 Feb; 216(1):35-45. PubMed ID: 8615005
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity study of HPV 6b virus-like particles].
Liu Y; Liu X; Frazer IH
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
[TBL] [Abstract][Full Text] [Related]
11. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.
Oldak M; Smola H; Aumailley M; Rivero F; Pfister H; Smola-Hess S
J Virol; 2004 Oct; 78(19):10738-46. PubMed ID: 15367640
[TBL] [Abstract][Full Text] [Related]
13. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Pinto LA; Viscidi R; Harro CD; Kemp TJ; García-Piñeres AJ; Trivett M; Demuth F; Lowy DR; Schiller JT; Berzofsky JA; Hildesheim A
Virology; 2006 Sep; 353(2):451-62. PubMed ID: 16863657
[TBL] [Abstract][Full Text] [Related]
15. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
Gambhira R; Jagu S; Karanam B; Gravitt PE; Culp TD; Christensen ND; Roden RB
J Virol; 2007 Nov; 81(21):11585-92. PubMed ID: 17715230
[TBL] [Abstract][Full Text] [Related]
16. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.
Rommel O; Dillner J; Fligge C; Bergsdorf C; Wang X; Selinka HC; Sapp M
J Med Virol; 2005 Jan; 75(1):114-21. PubMed ID: 15543569
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
20. Response to IL-6 of HPV-18 cervical carcinoma cell lines.
Bauknecht T; Randelzhofer B; Schmitt B; Ban Z; Hernando JJ
Virology; 1999 Jun; 258(2):344-54. PubMed ID: 10366571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
